Angelina Jolie part of a clever corporate scheme to protect billions in BRCA gene patents

"'Natural News' has learned it all coincides with a well-timed for-profit corporate P.R. campaign that has been planned for months and just happens to coincide with the upcoming U.S. Supreme Court decision on the viability of the BRCA1 patent."